BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/6/2016 4:53:00 PM | Browse: 1481 | Download: 1587
 |
Received |
|
2016-03-15 09:50 |
 |
Peer-Review Started |
|
2016-03-18 09:16 |
 |
To Make the First Decision |
|
2016-05-12 09:14 |
 |
Return for Revision |
|
2016-05-16 14:59 |
 |
Revised |
|
2016-05-25 15:59 |
 |
Second Decision |
|
2016-05-31 15:21 |
 |
Accepted by Journal Editor-in-Chief |
|
2016-05-31 15:33 |
 |
Accepted by Executive Editor-in-Chief |
|
2016-06-13 17:45 |
 |
Articles in Press |
|
2016-06-13 17:45 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2016-06-30 19:42 |
 |
Publish the Manuscript Online |
|
2016-07-06 16:53 |
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Oncology |
Manuscript Type |
Topic Highlights |
Article Title |
Exploring the role of molecular biomarkers as a potential weapon against gastric cancer: A review of the literature
|
Manuscript Source |
Invited Manuscript |
All Author List |
Marwa Matboli, Sarah El-Nakeep, Nourhan Hossam, Alaa Habieb, Ahmed EM Azazy, Ali E Ebrahim, Ziad Nagy and Omar Abdel-Rahman |
Funding Agency and Grant Number |
|
Corresponding Author |
Dr. Omar Abdel-Rahman, Clinical Oncology and Nuclear Medicine Department, Faculty of Medicine, Ain Shams University, Cairo 113331, Egypt. omar.abdelrhman@med.asu.edu.eg |
Key Words |
Gastric cancer; Molecular therapy; Targeted therapy; Biomarkers; Bioinformatics |
Core Tip |
We tried to highlight the role of molecular biomarkers as a predictor to chemotherapeutic response to existing regimens, aiming for better personalized therapy. Also we provided a summary of molecular markers that may aid in the development of rational therapeutic options for gastric cancer (GC) patients, aiming for improving their outcomes. However, among the plethora of agents targeting VEGF, EGFR, HER-2, IGF and mTOR pathways, trastuzumab and ramucirumab have been the only approved therapeutic options for use in advanced GC. Despite having many promising studies in their early stages, a lot have failed to prove their effectiveness in GC on the long run. |
Publish Date |
2016-07-06 16:53 |
Citation |
Matboli M, El-Nakeep S, Hossam N, Habieb A, Azazy AEM, Ebrahim AE, Nagy Z, Abdel-Rahman O. Exploring the role of molecular biomarkers as a potential weapon against gastric cancer: A review of the literature. World J Gastroenterol 2016; 22(26): 5896-5908 |
URL |
http://www.wjgnet.com/1007-9327/full/v22/i26/5896.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v22.i26.5896 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345